These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

642 related articles for article (PubMed ID: 26958036)

  • 1. Adverse drug reaction reporting among health care workers at Mulago National Referral and Teaching hospital in Uganda.
    Katusiime B; Semakula D; Lubinga SJ
    Afr Health Sci; 2015 Dec; 15(4):1308-17. PubMed ID: 26958036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Awareness, knowledge, attitude and practice of adverse drug reaction reporting among health workers and patients in selected primary healthcare centres in Ibadan, southwestern Nigeria.
    Adisa R; Omitogun TI
    BMC Health Serv Res; 2019 Dec; 19(1):926. PubMed ID: 31796034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing spontaneous adverse drug reaction reporting in public healthcare setting in Namibia.
    Adenuga BA; Kibuule D; Rennie TW
    Basic Clin Pharmacol Toxicol; 2020 Mar; 126(3):247-253. PubMed ID: 31520574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knowledge, Practice and Attitudes Toward Pharmacovigilance and Adverse Drug Reactions Reporting Process Among Health Care Providers in Dammam, Saudi Arabia.
    Ali MD; Hassan YA; Ahmad A; Alaqel O; Al-Harbi H; Al-Suhaimi NM
    Curr Drug Saf; 2018; 13(1):21-25. PubMed ID: 29256354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition and reporting of suspected adverse drug reactions by surveyed healthcare professionals in Uganda: key determinants.
    Kiguba R; Karamagi C; Waako P; Ndagije HB; Bird SM
    BMJ Open; 2014 Nov; 4(11):e005869. PubMed ID: 25421337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.
    Tandon VR; Mahajan V; Khajuria V; Gillani Z
    Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthcare personnel's experience of reporting adverse drug reactions in Baghdad city: cross-sectional study.
    Hussain SA; Abbas AN; Habeeb SA; Abd-Ali AK; Abdulrahman ZS
    Int J Clin Pharm; 2019 Oct; 41(5):1307-1313. PubMed ID: 31240554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with spontaneous adverse drug reaction reporting among healthcare professionals in Vietnam.
    Le TT; Nguyen TTH; Nguyen C; Tran NH; Tran LA; Nguyen TB; Nguyen N; Nguyen HA
    J Clin Pharm Ther; 2020 Feb; 45(1):122-127. PubMed ID: 31486525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facilitators and Barriers to Uptake of the Med Safety Mobile App for Adverse Drug Reaction Reporting by Health Workers in Uganda: A Qualitative Study.
    Kiguba R; Zakumumpa H; Ndagije HB; Mwebaza N; Ssenyonga R; Tregunno P; Harrison K; Pirmohamed M
    Drug Saf; 2023 Jun; 46(6):565-574. PubMed ID: 37097426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knowledge, attitude and practice of physicians and nurses at the cape coast teaching hospital in the Central Region of Ghana on spontaneous adverse drug reaction reporting.
    Powell JF; Henneh IT; Ekor M
    PLoS One; 2023; 18(7):e0288100. PubMed ID: 37418384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knowledge of Adverse Drug Reaction Reporting Among Healthcare Professionals in Bhutan: A Cross-Sectional Survey.
    Dorji C; Tragulpiankit P; Riewpaiboon A; Tobgay T
    Drug Saf; 2016 Dec; 39(12):1239-1250. PubMed ID: 27743333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knowledge, attitude and practices associated with adverse drug reaction reporting amongst doctors in a teaching hospital.
    Chopra D; Wardhan N; Rehan HS
    Int J Risk Saf Med; 2011; 23(4):227-32. PubMed ID: 22156087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study.
    Jacobs TG; Hilda Ampadu H; Hoekman J; Dodoo ANO; Mantel-Teeuwisse AK
    BMC Public Health; 2018 Dec; 18(1):1384. PubMed ID: 30563498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge, awareness, perception and reporting of experienced adverse drug reactions among outpatients in Nigeria.
    Adisa R; Adeniyi OR; Fakeye TO
    Int J Clin Pharm; 2019 Aug; 41(4):1062-1073. PubMed ID: 31140162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the factors and barriers of healthcare professionals in tertiary care hospitals toward pharmacovigilance: a multicenter study from Khyber Pakhtunkhwa, Pakistan.
    Sharif MJH; Farrukh MJ; Khan FU; Khan Q; Ahmed SS; Kousar R; Ahmad T; Abid SMA; Ashfaq M; Khan SA
    Curr Med Res Opin; 2022 Apr; 38(4):595-605. PubMed ID: 35166143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse Drug Reaction Monitoring and Reporting Among Physicians and Pharmacists in Pakistan: A Cross-sectional Study.
    Nisa ZU; Zafar A; Zafar F; Pezaro S; Sher F
    Curr Drug Saf; 2020; 15(2):137-146. PubMed ID: 32338223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of awareness about pharmacovigilance and adverse drug reaction monitoring in resident doctors of a tertiary care teaching hospital.
    Pimpalkhute SA; Jaiswal KM; Sontakke SD; Bajait CS; Gaikwad A
    Indian J Med Sci; 2012; 66(3-4):55-61. PubMed ID: 23603621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse drug reaction reporting practice and associated factors among medical doctors in government hospitals in Addis Ababa, Ethiopia.
    Nadew SS; Beyene KG; Beza SW
    PLoS One; 2020; 15(1):e0227712. PubMed ID: 31961883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacovigilance amongst patent medicine vendors (PMVs) in Ekiti state, Nigeria.
    Awodele O; Adeniran A; Awodele DF
    Int J Risk Saf Med; 2012; 24(2):65-72. PubMed ID: 22751188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.